Skip to main content

Q&As

Rheumatology Consultant
May 20, 2020
Steven Romano, MD, executive vice president and chief scientific officer at Mallinckrodt, answers our questions about his team’s research on the effects of Acthar therapy on patients with rheumatoid arthritis.
Gastroenterology Consultant
May 20, 2020
In a new study, researchers sought to clarify how the gut microbe may influence chronic gastrointestinal disease. The coauthors Michael C. Hoaglin, MD and Melissa Agnello, PhD answered our questions about their research.
The Dermatologist
April 29, 2020
While the upper respiratory tract symptoms of the novel SARS-CoV-2 virus are widely recognized, new reports are suggesting possible skin manifestations among patients with the COVID-19. In an interview with The Dermatologist, Esther Freeman, MD, PhD, principle investigator, discussed the COVID-19…
Rheumatology Consultant
April 23, 2020
Lead author Lihi Eder, MD, PhD, answers our questions about her study that evaluated musculoskeletal issues preceding patients’ diagnosis of psoriatic arthritis. This period may represent a window for earlier diagnosis of PsA.
The Dermatologist
April 13, 2020
Psoriasis is associated with many comorbid conditions. In an interview with The Dermatologist, Ronald Prussick, MD, discusses the latest research on these comorbidities, evidence on lifestyle and treatment options that could potentially prevent or manage both psoriasis and comorbid conditions, and…
The Dermatologist
April 07, 2020
Jules Lipoff, MD, spoke with The Dermatologist about treating patients with blistering autoimmune disease during the COVID-19 pandemic, including treatment considerations and common questions patients are asking.
Rheumatology Consultant
April 01, 2020
Yun Gao, MD, and Xiang Gao, MD, PhD, answer our questions about their research on the impact of the DASH diet on hyperuricemia in patients without gout.
Gastroenterology Consultant
March 31, 2020
Joshua Z. Goldenberg, ND, answered our questions about his team’s study aimed to assess the efficacy and safety of biofeedback-based interventions for treating irritable bowel syndrome among adults and children.
ALN
March 30, 2020
Dr Sonpal addresses common questions patients are asking about COVID-19, how hospitals and practices are following sanitary measures to reduce potential exposure between patients, and the reports on gastrointestinal symptoms.
The Dermatologist
March 27, 2020
As of March 27, 2020, the United States has become the epicenter of the coronavirus pandemic. Misha Rosenbach, MD, answered several questions regarding the current pandemic.
Back to Top